Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | |||||||||
| Earning before tax | ---- | 167.63%500.7M | 133.43%295.05M | ---- | 81.41%187.09M | --126.4M | --72.1M | 147.57%103.13M | --41.66M |
| Profit adjustment | |||||||||
| Impairment and provisions: | ---- | -197.12%-708K | -306.31%-425K | ---- | 24,400.00%729K | --206K | --817K | -100.69%-3K | --432K |
| -Impairment of trade receivables (reversal) | ---- | -197.12%-708K | -306.31%-425K | ---- | 24,400.00%729K | --206K | --817K | -100.69%-3K | --432K |
| Asset sale loss (gain): | ---- | --1K | --1K | ---- | ---- | ---- | ---- | 50.00%6K | --4K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | --1K | --1K | ---- | ---- | ---- | ---- | 50.00%6K | --4K |
| Depreciation and amortization: | ---- | 6.13%60.32M | 11.27%46.2M | ---- | 27.64%56.84M | --41.52M | --27.89M | 92.49%44.53M | --23.13M |
| -Amortization of intangible assets | ---- | 73.78%676K | 191.33%504K | ---- | 59.43%389K | --173K | --129K | 52.50%244K | --160K |
| Financial expense | ---- | 200.00%6K | 200.00%3K | ---- | 0.00%2K | --1K | --1K | 100.00%2K | --1K |
| Special items | ---- | 1,240.00%2M | ---- | ---- | ---175K | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | 130.01%562.32M | 102.72%340.83M | ---- | 65.56%244.48M | --168.12M | --100.81M | 126.38%147.67M | --65.23M |
| Change of operating capital | |||||||||
| Inventory (increase) decrease | ---- | 150.85%30.26M | 227.29%36.66M | ---- | -178.30%-59.52M | ---28.8M | ---39.61M | 55.91%-21.39M | ---48.5M |
| Accounts receivable (increase)decrease | ---- | 143.08%22.33M | 284.82%17.47M | ---- | -1,692.93%-51.83M | ---9.45M | ---31.5M | 121.51%3.25M | ---15.13M |
| Accounts payable increase (decrease) | ---- | -479.63%-28.07M | 199.31%32.22M | ---- | -16.06%7.39M | --10.76M | --52.76M | 4.87%8.81M | --8.4M |
| prepayments (increase)decrease | ---- | 130.22%15.01M | 291.48%16.54M | ---- | -251.92%-49.66M | ---8.64M | --5.91M | 310.67%32.69M | ---15.52M |
| Special items for working capital changes | ---- | -105.39%-439K | -182.10%-14.07M | ---- | 202.80%8.14M | --17.13M | --6.42M | -148.03%-7.92M | ---3.19M |
| Cash from business operations | 29.52%321.99M | 507.42%601.41M | 188.10%429.65M | 162.30%248.6M | -39.30%99.01M | --149.13M | --94.78M | 1,972.87%163.11M | ---8.71M |
| Other taxs | -98.93%-14.72M | -614.23%-19.58M | -170.01%-7.4M | ---7.4M | -3,760.56%-2.74M | ---2.74M | ---- | ---71K | ---- |
| Net cash from operations | 27.39%307.27M | 504.38%581.83M | 188.44%422.25M | 154.49%241.2M | -40.95%96.27M | --146.39M | --94.78M | 1,972.05%163.04M | ---8.71M |
| Cash flow from investment activities | |||||||||
| Decrease in deposits (increase) | ---13.16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | -99.78%1K | -97.83%1K | ---- | --453K | --46K | --2K | ---- | ---- |
| Purchase of fixed assets | -244.14%-244.06M | -271.92%-270.76M | -156.15%-150.93M | -31.61%-70.92M | 49.87%-72.8M | ---58.92M | ---53.89M | -12.86%-145.23M | ---128.69M |
| Purchase of intangible assets | ---- | -54.01%-2.83M | ---- | ---- | 64.27%-1.84M | ---- | ---- | 41.58%-5.14M | ---8.79M |
| Net cash from investment operations | -262.69%-257.22M | -268.80%-273.58M | -156.35%-150.93M | -31.61%-70.92M | 50.67%-74.18M | ---58.88M | ---53.89M | -9.38%-150.37M | ---137.48M |
| Net cash before financing | -70.61%50.05M | 1,295.63%308.25M | 210.03%271.32M | 316.42%170.28M | 74.37%22.09M | --87.51M | --40.89M | 108.66%12.67M | ---146.19M |
| Cash flow from financing activities | |||||||||
| New borrowing | ---- | 1,183.52%17.44M | 1,713.34%12.37M | 2,535.00%10.01M | 94.14%1.36M | --682K | --380K | 75.00%700K | --400K |
| Refund | ---- | -733.33%-18.35M | -154.03%-5.61M | -5,490.63%-5.37M | -103.32%-2.2M | ---2.21M | ---96K | -720.45%-1.08M | ---132K |
| Issuing shares | --298.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---3K | ---3K | ---1K | ---- | ---- | ---- | ---- | ---- | ---- |
| Dividends paid - financing | -842.27%-267.06M | -234.42%-95.03M | -234.59%-95.08M | ---28.34M | ---28.42M | ---28.42M | ---- | ---- | ---- |
| Absorb investment income | ---- | -99.85%50K | ---- | ---- | --34.47M | --34.47M | --6.67M | ---- | --158.92M |
| Issuance expenses and redemption of securities expenses | -68.29%-207K | -420.48%-432K | ---425K | ---123K | ---83K | ---- | ---- | ---- | ---- |
| Net cash from financing operations | 229.86%30.93M | -1,979.89%-96.36M | -2,062.02%-88.76M | -442.77%-23.82M | 1,438.38%5.13M | --4.52M | --6.95M | -100.24%-383K | --159.19M |
| Effect of rate | 33.43%-7.92M | -302.15%-9.3M | 302.29%5.09M | -274.25%-11.9M | 125.90%4.6M | --1.26M | --6.83M | -153.55%-17.76M | ---7.01M |
| Net Cash | -44.71%80.98M | 678.64%211.89M | 98.35%182.56M | 206.15%146.46M | 121.53%27.21M | --92.04M | --47.84M | -5.51%12.28M | --13M |
| Begining period cash | 80.53%454.15M | 14.48%251.56M | 14.48%251.56M | 14.48%251.56M | -2.43%219.75M | --219.75M | --219.75M | 2.73%225.23M | --219.23M |
| Cash at the end | 36.54%527.21M | 80.53%454.15M | 40.30%439.2M | 40.71%386.12M | 14.48%251.56M | --313.05M | --274.42M | -2.43%219.75M | --225.23M |
| Cash balance analysis | |||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | PwC accounting firm | -- | -- | PwC accounting firm | -- | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.